We are live on ! Find out more

2,952 hedge funds and large institutions have $151B invested in Merck in 2022 Q1 according to their latest regulatory filings, with 187 funds opening new positions, 1,422 increasing their positions, 1,008 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 104

74% more funds holding in top 10

Funds holding in top 10: 62108 (+46)

43% more call options, than puts

Call options by funds: $2.45B | Put options by funds: $1.72B

41% more repeat investments, than reductions

Existing positions increased: 1,422 | Existing positions reduced: 1,008

7% more capital invested

Capital invested by funds: $142B → $151B (+$9.34B)

2% more funds holding

Funds holding: 2,9022,952 (+50)

0.16% less ownership

Funds ownership: 73.46%73.3% (-0.16%)

Holders
2,952
Holders Change
+50
Holders Change %
+1.72%
% of All Funds
46.56%
Holding in Top 10
108
Holding in Top 10 Change
+46
Holding in Top 10 Change %
+74.19%
% of All Funds
1.7%
New
187
Increased
1,422
Reduced
1,008
Closed
104
Calls
$2.45B
Puts
$1.72B
Net Calls
+$734M
Net Calls Change
-$467M
Name Holding Trade Value Shares
Change
Change in
Stake
LKIM
2176
Lawson Kroeker Investment Management
Nebraska
$533K
CCM
2177
Carlson Capital Management
Minnesota
$529K +$1.42K +18 +0.3%
CA
2178
CoreCap Advisors
Michigan
$529K +$6.78K +86 +1%
RCM
2179
RB Capital Management
Nevada
$528K +$158 +2 +0%
SFP
2180
Sweet Financial Partners
Minnesota
$527K +$12.1K +153 +2%
KPW
2181
Kore Private Wealth
New York
$527K +$36.8K +467 +8%
LK
2182
Lumbard & Kellner
New Hampshire
$526K
PP
2183
PDS Planning
Ohio
$526K +$130K +1,652 +35%
PL
2184
Pluribus Labs
California
$526K +$505K +6,405 New
MSR
2185
Main Street Research
Connecticut
$523K -$74.6K -946 -13%
EW
2186
Evoke Wealth
California
$523K +$8.75K +111 +2%
PA
2187
PSI Advisors
Florida
$523K +$72.6K +921 +17%
MCA
2188
MSH Capital Advisors
Arizona
$521K +$23.2K +294 +5%
APA
2189
Astoria Portfolio Advisors
New York
$520K -$97.3K -1,234 -16%
MTIC
2190
Missouri Trust & Investment Company
Missouri
$520K -$9.86K -125 -2%
BCM
2191
Boltwood Capital Management
California
$520K
CH
2192
Canton Hathaway
Rhode Island
$519K
WTFG
2193
Wells Trecaso Financial Group
Ohio
$518K +$1.97K +25 +0.4%
EFM
2194
E Fund Management
China
$517K -$77.2K -979 -13%
SIM
2195
SSI Investment Management
California
$517K -$5.83K -74 -1%
PCM
2196
Princeton Capital Management
New Jersey
$517K +$2.76K +35 +0.6%
ESCM
2197
Echo Street Capital Management
New York
$516K -$957K -12,132 -66%
ACS
2198
Archford Capital Strategies
Illinois
$516K +$112K +1,419 +30%
FDS
2199
First Dallas Securities
Texas
$515K +$27.6K +350 +6%
TF
2200
Trek Financial
Arizona
$513K -$189K -2,403 -28%

MRK Hedge Fund Activity: Q1 2022 in Review

2,952 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2022, worth a combined $151B — up 6.6% from $142B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 104 closed out — a net gain of 83 holders — while 1,422 added to existing stakes and 1,008 trimmed.

The largest buyer was Marshall Wace, adding an estimated $532M. The largest seller was Franklin Resources, cutting an estimated $1.25B.

  • 2,952 institutional investors held Merck (MRK) as of Q1 2022, up from 2,902 in Q4 2021.
  • Funds reported $151B of Merck stock for Q1 2022, up 6.6% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q1 2022 and 104 closed out, a net change of +83 holders.
  • The largest Merck buyer in Q1 2022 was Marshall Wace, an estimated $532M added.
  • The largest Merck seller in Q1 2022 was Franklin Resources, an estimated $1.25B sold.

Based on aggregated 13F filings for Q1 2022.